Global Oncology Information System Market is Poised to Value Over $4 Billion by 2026 End

  • 08 Apr 2019

The inclination towards automation and dependency on computationally processed data to facilitate patient data record maintenance at a single location makes oncology information systems(OIS) a popular software amongst physicians and hospitals. OIS helps plan, manage and predict treatment module for cancer patients that serve an additional advantage over conventional record maintenance systems. Oncology research initiatives, rise in ageing population, a significant increase in the number of cancer patients, hundreds of types of cancer requiring unique diagnostics, and implementation of healthcare policies that encourage smart technologies is boosting robust growth of oncology information systems market.
Global Oncology Information System Market is poised to value over $4 Billion by 2026 end and expected to register at CAGR 7.8% for forecast period 2019-2026. 

 

Global Oncology Information System Market Restraints

•    High implementation, maintenance and services costs of OIS
•    Lack of trained healthcare IT professional to use, analyse and interpret OIS data


Usage of hormonal therapy, immunotherapy, chemotherapy, is expected to impel the application segment growth during the forecasted period. Advancement in technology is experiencing positive investment flow from various research and development organisations as they estimate millions of new cases of cancer to emerge in the next decade that needs to be handled efficiently. Digitization in the healthcare sector, the high incidences of various cancer types including lung cancer, breast cancer, cancer during pregnancy, etc especially in the U.S and emerging nations in the world, to drive the OIS market at a peak in years to come.


With the onset of IT disruption, need to facilitate shared systems and data beyond physical borders makes it possible to implement software either on-premise or buying licensed cloud-based software. Cloud-based systems save on high-cost infrastructure, in the long run, hence, cloud-based treatment planning systems are expected to grow at highest CAGR during the forecast period.
 

North America and Europe are major dominators in the global oncology information system market as this region has the highest number of established healthcare systems, research activities and predominant high penetration. While North America is expected to hold largest market share in terms of revenue, Asia-pacific is demonstrating tremendous prospects due to medical tourism, government initiatives for cancer patients and exploding population rate and is expected to register highest CAGR throughout the forecast period. Latin America and Rest of World Oncology information systems market is expected to witness slow growth over the forecast period due to slow adoption.

The Global Oncology Information System market is segmented by application, deployment, end users and region.
 

Global Oncology Information System Market, by Application

•    Surgical Oncology
•    Radiation Oncology 

Global Oncology Information System Market, by Deployment

•    On-premise
•    Cloud-Based

Global Oncology Information System Market, by End User
•    Hospitals
•    Diagnostic Laboratories
•    Outpatient Centres
•    Clinics

Global Oncology Information System Market, by Region
•    Europe  
•    North America  
•    APAC  
•    Latin America
•    Rest of World

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share  
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  
FutureWise Takeaways  
•    Growth prospects  
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth  

 

Objectives of the Study:
•    To provide with an exhaustive analysis on global oncology information system market by application, deployment type, end-user and region 
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market  
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contacsales@futurewiseresearch.com